tiprankstipranks
Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
Hong Kong Market
2509
Qyuns Therapeutics Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2509 full AI Analyst Report?

Qyuns Therapeutics Co., Ltd. Class H (2509) Financial Statements

1 Followers

Qyuns Therapeutics Co., Ltd. Class H Financial Overview

Qyuns Therapeutics Co., Ltd. Class H's market cap is currently HK$3.91B. The company's EPS TTM is HK$-0.86; its P/E ratio is 12.32; Qyuns Therapeutics Co., Ltd. Class H is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 786.08M¥ 158.79M¥ 14.75M¥ 9.66M¥ 21.35M
Gross Profit¥ 664.66M¥ 92.19M¥ 14.75M¥ -25.85M¥ -9.56M
Operating Income¥ 319.74M¥ -326.37M¥ -504.51M¥ -293.69M¥ -168.62M
EBITDA¥ 351.00M¥ -311.82M¥ -484.12M¥ -295.51M¥ -155.65M
Net Income¥ 306.31M¥ -335.57M¥ -507.75M¥ -298.19M¥ -411.04M
Balance Sheet
Cash & Short-Term Investments¥ 1.04B¥ 556.55M¥ 377.25M¥ 689.57M¥ 620.44M
Total Assets¥ 1.60B¥ 983.88M¥ 795.58M¥ 1.16B¥ 1.31B
Total Debt¥ 580.26M¥ 527.60M¥ 346.06M¥ 295.25M¥ 290.26M
Net Debt¥ -381.90M¥ 166.91M¥ 129.76M¥ 92.25M¥ 88.33M
Total Liabilities¥ 921.62M¥ 762.83M¥ 494.63M¥ 419.55M¥ 444.45M
Stockholders' Equity¥ 694.33M¥ 228.98M¥ 324.54M¥ 641.72M¥ 670.35M
Cash Flow
Free Cash Flow¥ 392.23M¥ -186.09M¥ -308.63M¥ -301.70M¥ -228.64M
Operating Cash Flow¥ 399.85M¥ -186.09M¥ -300.68M¥ -275.23M¥ -157.60M
Investing Cash Flow¥ 118.69M¥ -25.23M¥ 243.11M¥ -5.70M¥ -306.69M
Financing Cash Flow¥ 93.73M¥ 351.81M¥ 61.21M¥ 211.49M¥ 281.48M
Currency in CNY

Qyuns Therapeutics Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Qyuns Therapeutics Co., Ltd. Class H Debt to Assets

Balance Sheet >

Qyuns Therapeutics Co., Ltd. Class H Cash Flow

Cash Flow >

Qyuns Therapeutics Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >